Moise Liviu Marius

Dr. Moise Liviu Marius


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IHIngrid Henriette Iris Hrubaru
Ingrid Henriette Iris Hrubaru
AMAndrei Gheorghe Marius Motoc
Andrei Gheorghe Marius Motoc
MMMoise Liviu Marius
Moise Liviu Marius
BMBogdan Miutescu
Bogdan Miutescu
ICIoana Mihaela Citu
Ioana Mihaela Citu
CCCosmin Ioan Citu
Cosmin Ioan Citu
In many countries, preterm birth, defined as birth before 37 completed weeks of gestation, is the primary cause of infant death and morbidity. An increasing body of research suggests that inflammation (both clinical and subclinical) plays a significant role in inducing preterm labor or developing pregnancy problems that lead to premature birth. Consequently, the purpose of this research was to determine the predictive value of the Neutrophil-Lymphocyte Ratio (NLR), derived Neutrophil-Lymphocyte Ratio (dNLR), Monocytes-to-Lymphocyte Ratio (MLR), Platelets-to-Lymphocyte Ratio (PLR), Systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI), for premature delivery. A retrospective study analyzed a total of 243 eligible pregnancies that resulted in a preterm birth during 2020 and 2021. A control group without a history of preterm birth was matched by age and trimester of laboratory analysis at a 1:1 ratio. Although the number of comorbidities was similar among study groups, the body-mass index estimated for the week of gestation was significantly higher among the patients from the prematurity group, as well as the prevalence of urinary tract infections and smoking. Laboratory data showed that patients with a preterm birth had significantly higher white blood cell count and monocytes, but significantly lower lymphocytes, platelets, and hemoglobin. The NLR, dNLR, PLR, and MLR scores showed to be significantly higher among patients from the prematurity group, but SII and SIRI were not significantly different between the study groups. It was observed that the AUC values of NLR, dNLR, PLR, and MLR were higher than 0.600, respectively NLR had the highest value among the tested scores (AUC = 0.694) and the highest sensitivity in this study (71%). The highest sensibility was achieved by dNLR, with 70%, and an AUC value of 0.655 (p-value = 0.022). PLR had the second-highest AUC value (0.682) and the best score in terms of sensitivity (70%) and sensibility (69%) (p-value = 0.015). Lastly, MLR had the lowest significant AUC score (0.607) and lowest sensitivity/sensibility. The significant cut-off values for the inflammatory scores were 9.0 for NLR, 9.8 for dNLR, 250 for PLR, and 4.07 for MLR. After evaluating the importance of these inflammatory scores, further clinical applications should be conducted to confirm the results and improve therapy and care to reduce the burden of premature deliveries.

23 January 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
ATAna-Olivia Toma
Ana-Olivia Toma
EBEstera Boeriu
Estera Boeriu
LDLuminița Emilia Decean
Luminița Emilia Decean
VBVlad Bloanca
Vlad Bloanca
Felix BratosinFelix Bratosin
Felix Bratosin
MMMoise Liviu Marius
Moise Liviu Marius
Almost one-third of all malignant melanoma patients exhibit emotional stress indicating the need for professional care. Considering this, patients’ psychological needs are routinely overlooked and unfulfilled, even though there is substantial evidence that psychological therapies may enhance psychosocial outcomes for melanoma patients, such as low mood, sadness, and anxiety. Among developing countries and some health systems in developed regions, the lack of awareness and screening methods for skin cancer creates a high risk of psychological issues associated with more advanced diseases. Therefore, the current study aimed to investigate and compare the impact of malignant melanoma awareness for screening, prevention, and treatment on the patient’s quality of life and coping with stress and depression, based on patients’ age. This cross-sectional study recruited 238 patients with malignant melanoma distributed into two groups, Group A patients between 18 and 65 years and Group B patients older than 65. There were no significant gender differences and cancer staging differences between groups, although self-reported depressed mood and anhedonia were significantly more frequent in younger adults with malignant melanoma (43.8% vs. 28.9%). From the unstandardized surveys, it was observed that significantly fewer patients from Group B knew that melanoma could be caused by sun exposure (34.2% vs. 52.2%), and they were less likely to use sunscreen or visit a doctor to evaluate their skin moles (25.9% vs. 14.5%). Elderly patients preferred television as the main source of information, and only 68.4% of patients from Group B were using smart devices. There was a significantly higher physical score on the SF-12 scale among Group A patients, although patients from Group B scored higher in the mental health assessment, and the perceived helplessness on the PSS-10 scale was significantly higher compared to younger adults with melanoma (2.97 vs. 2.71, p-value = 0.036). Lower scores on the physical and mental SF-12 questionnaire determined a higher presence of depressive symptoms (rho = −0.352, respectively rho = −0.273). Higher scores on the DLQI sexual difficulties and treatment difficulties also correlated significantly with the presence of depressive symptoms and anhedonia (rho = 0.341, respectively rho = 0.264). Awareness campaigns for malignant melanoma should focus on the elderly population, too, using the television as the main communication channel. On the other hand, the more informed and knowledgeable group of adults younger than 65 are more likely to experience psychological problems and should be targeted for psycho-oncological aid.

Verified
Journal Article
Open access
PDF file
IHIngrid Henriette Iris Hrubaru
Ingrid Henriette Iris Hrubaru
AMAndrei Gheorghe Marius Motoc
Andrei Gheorghe Marius Motoc
Felix BratosinFelix Bratosin
Felix Bratosin
OROvidiu Rosca
Ovidiu Rosca
RFRoxana Folescu
Roxana Folescu
CCCosmin Ioan Citu
Cosmin Ioan Citu
Studies observed that women infected with SARS-CoV-2 during pregnancy had a higher risk of preterm birth. Although it is likely that COVID-19 during the late trimester of pregnancy can trigger premature birth, prematurity remains a concern, and it is vital to study additional clinical and biological patient factors that are highly associated with this negative pregnancy outcome and allow for better management based on the existing predictors. In order to achieve this goal, the current study retrospectively recruited 428 pregnant patients that were separated into three study groups using a 1:2:4 matching ratio and a nearest-neighbor matching method. Sixty-one pregnant patients had a history of COVID-19 during pregnancy and gave birth prematurely; 124 pregnant patient controls had COVID-19 and gave birth full-term, while the second control group of 243 pregnant patients had a premature birth but no history of COVID-19. It was observed that a symptomatic SARS-CoV-2 infection during the third trimester was significantly more likely to be associated with premature birth. Even though the rate of ICU admission was higher in these cases, the mortality rate did not change significantly in the COVID-19 groups. However, SARS-CoV-2 infection alone did not show statistical significance in determining a premature birth (β = 1.09, CI = 0.94–1.15, p-value = 0.067). Maternal anemia was the strongest predictor for prematurity in association with SARS-CoV-2 infection (β = 3.65, CI = 1.46–5.39, p-value < 0.001), followed by elevated CRP (β = 2.11, CI = 1.20–3.06, p-value < 0.001), and respectively IL-6 (β = 1.92, CI = 1.20–2.47, p-value = 0.001. SARS-CoV-2 infection is associated with an increased risk of preterm birth, as shown by our data. If SARS-CoV-2 infection arises during the third trimester, it is recommended that these patients be hospitalized for surveillance of clinical evolution and biological parameters, such as anemia and high inflammatory markers, which have a multiplicative influence on the pregnancy result.

29 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SHSamer Hosin
Samer Hosin
DVDinu Vermesan
Dinu Vermesan
RPRadu Prejbeanu
Radu Prejbeanu
DCDan Crisan
Dan Crisan
MAMusab Al-Qatawneh
Musab Al-Qatawneh
CPCiprian Nicolae Pilut
Ciprian Nicolae Pilut
There is still no general agreement about the most effective form of syndesmosis fixation with syndesmotic screws for patients affected by ankle fractures that are accompanied by syndesmotic injuries. In the same manner, no consensus has been reached yet on whether or not the tibiofibular syndesmotic screw is more beneficial if removed or not, as well as the exact timing of removal if this proves superiority. The purpose of this research was to verify whether or not removing syndesmotic screws reduces the risk of developing a diastasis and compare outcomes in patients whose syndesmotic screw was or was not removed at all. A retrospective observational study was carried out to cover a period of five years and a computed sample size of almost 300 cases. Patients were included in the current study if their history was positive for ankle fracture with distal tibiofibular diastasis repair with syndesmotic screws. Loss of reduction was more frequent after screw removal (8.5% vs. 2.1%), although the quality of reduction was generally excellent in both groups. The mean AOFAS score was significantly better in patients who had their tibiofibular screw removed (92.6 vs. 88.4), but the tibiofibular clear space and incisura fibularis depth widened more following the second intervention (3.8 mm vs. 3.6 mm, and, respectively, 4.3 vs. 4.1). Lastly, the same patients with tibiofibular screw removal had a significantly higher cost of total interventions and more days of medical leave (21 vs. 15 days on average). It seems that a strong conclusion in favor of removing or not removing syndesmotic screws after distal tibiofibular diastasis repair cannot be given. However, several radiographic findings lean toward the benefit of those patients whose tibiofibular screws were not removed, although mobility was notably better after the screw was removed. Furthermore, treatment expenses are greatly lowered if a subsequent operation for screw removal is avoided, as well as if individuals who have a single surgery take a shorter medical leave.

1 October 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Cristina-Stefania DumitruCristina-Stefania Dumitru
Cristina-Stefania Dumitru
RPRaul Patrascu
Raul Patrascu
MMMoise Liviu Marius
Moise Liviu Marius
Background/Objectives: Chronic inflammation is increasingly recognized as a driver of head and neck squamous cell carcinoma (HNSCC) progression, but the interplay between local immune surveillance and angiolymphatic remodeling remains incompletely characterized. We hypothesized that advanced HNSCC stage would be associated with lower epithelial CD1a+ Langerhans cell density alongside higher proliferation, reduced E-cadherin-mediated adhesion, and higher angiogenic/lymphangiogenic activity, and aimed to relate this marker pattern to tumor stage defined by combined histopathological and radiological criteria. Methods: Fifty HNSCC specimens were included (mean age, 63.9 ± 8.7 years; 86% male; 88% current or former smokers). Specimens were evaluated immunohistochemically for CD1a (primary Langerhans cell metric) and S100 (supportive marker), Ki-67, E-cadherin, VEGF, and Ki-67/D2-40 double staining (proliferating lymphatic vessel density (pLVD), reported descriptively only), alongside hematoxylin and eosin (H&E)-based histological grading and combined histopathological/radiological (CT/MRI) staging. Associations were assessed using Spearman correlation, Mann–Whitney U/chi-square tests, and multivariable logistic regression. Results: CD1a+ epithelial density, the primary Langerhans-cell metric, was significantly lower in advanced-stage and node-positive tumors (median 22.30 vs. 32.75 cells/mm2, p = 0.0008; and 19.05 vs. 31.15 cells/mm2, p < 0.0001, respectively), while the Ki-67 index and VEGF immunoreactive score were correspondingly higher (all p ≤ 0.001), with a parallel decrease in E-cadherin H-score. CD1a+ density showed moderate inverse or direct correlations with the other evaluated markers (|ρ| = 0.56–0.64; all p < 0.001). On multivariable analysis, lower CD1a+ epithelial density remained associated with nodal disease (pathological or clinical/radiological nodal status) after adjustment for T category (OR = 5.98 per 10-cell/mm2 decrease; 95% CI, 1.75–20.35; p = 0.004), together with T category (OR = 12.07; 95% CI, 1.99–73.06; p = 0.007), a finding robust to marker specification in a sensitivity analysis using the S100/CD1a composite metric (OR = 5.55; 95% CI, 1.61–19.18; p = 0.007). Conclusions: In this cross-sectional cohort, lower epithelial CD1a+ Langerhans cell density was associated with advanced stage and nodal positivity and occurred alongside higher proliferative activity, higher VEGF expression, and lower E-cadherin expression. These routinely assessable tissue biomarkers may provide a feasible framework for future biomarker-based risk stratification and warrant investigation for potential diagnostic adjunctive value. However, prospective validation in independent cohorts, including formal assessment of diagnostic performance, is required before any diagnostic, prognostic, predictive, or treatment-selection role can be proposed.

2 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MMMoise Liviu Marius
Moise Liviu Marius
Cristina-Stefania DumitruCristina-Stefania Dumitru
Cristina-Stefania Dumitru
DNDorin Novacescu
Dorin Novacescu
ABAlina Cristina Barb
Alina Cristina Barb
DSDiana Szekely
Diana Szekely
RPRaul Patrascu
Raul Patrascu
Cervical lymph node status is the single most important prognostic determinant in head and neck squamous cell carcinoma (HNSCC), yet conventional gray-scale ultrasound relies on morphological criteria that only indirectly reflect the underlying biological process driving nodal progression: tumor angiogenesis. This narrative review focuses specifically on cervical lymph nodes and examines whether multiparametric ultrasound (B-mode, Doppler, elastography, and contrast-enhanced ultrasound [CEUS]) can serve as a non-invasive, repeatable surrogate for nodal angiogenic activity in HNSCC and outlines a practical framework for its use in the head and neck clinic; evidence on the primary tumor itself was outside this review’s scope. A narrative synthesis of the literature on angiogenesis biology in HNSCC and on multiparametric ultrasound of cervical lymph nodes was performed, drawing on systematic reviews, meta-analyses, and clinical pilot studies identified through PubMed-indexed sources. Vascular endothelial growth factor (VEGF)-driven neoangiogenesis is a recognized diagnostic, prognostic, and predictive biological axis in HNSCC. Ultrasound modalities that visualize or quantify microvascular architecture and perfusion—Doppler vascularity patterns, shear-wave elastography, and CEUS—track features that are biologically continuous with angiogenesis (disorganized, high-permeability neovessels; altered tissue stiffness from stromal remodeling). Combining CEUS with B-mode ultrasound improves diagnostic accuracy for inconclusive cervical lymph nodes compared with either modality alone, and pilot multiparametric protocols in HNSCC show reproducible irregular contrast enhancement and elastographic heterogeneity in metastatic nodes. Multiparametric ultrasound does not replace histology, but it offers a repeatable, radiation-free, low-cost window onto the vascular phenotype of HNSCC that complements morphological staging. Given the heterogeneity and methodological limitations of the available evidence, multiparametric ultrasound should currently be regarded as a promising imaging biomarker rather than an established non-invasive surrogate for angiogenesis. Larger prospective, HNSCC-specific cohorts using standardized acquisition protocols, with direct histological correlation, are needed before this approach can be adopted into routine diagnostic pathways.